The objective of the RA and SLE AMP is to design and conduct cutting-edge molecular de-construction of the cellular, genetic, and immunologic pathways of RA and SLE. The goal of the Leadership Center (LC) is to establish a collaborative network comprised of the LC and multiple Research Sites (RS), operating a program that is both scientifically and financially efficient. LCMP Components A and B (Project and Operational Management) will establish procedures for monitoring, reporting and assessing the progress of the RS and LC. In collaboration with the NLC, it will establish and implement SOPs. It will establish an integrated, AMP Network-wide project management infrastructure, and information technology for tracking and reporting all of the key activities of the AMP Network. LCMP Component C, Data Coordination and Management (DCM) will define and manage shared computational and data acquisition and create data capture protocols and interface with clinical phenotype, tissue sample and molecular assay domains, and provide training to AMP staff. LCMP Component D, Statistical Research (SR) will devise, assess and optimize quality control pipelines for phase 0 and P&F studies, conduct analyses of phase 1 data in order to recommend study designs for phase 2. It will define standards for analyses and ensure broad use of AMP data by internal an external researchers. Systems Biology and Bioinformatics (SysBio) will devise focused algorithms to analyze individual molecular data types and integrative algorithms to analyze multiple types of data in aggregate. It will generate falsifiable hypotheses linking molecular data to clinical phenotypes and assess the credibility of proposed hypotheses. The Tissue Acquisition and Research Group (TRG) will develop standardized methods for sample collection, processing and storage, QA samples and provide a computerized and centralized sample tracking system. Together, these components of the LC will provide the support and infrastructure for operation of the AMP Network toward its goals of identifying biomarkers and targets for treating RA and SLE.
Rheumatoid Arthritis and Systemic Lupus Erythematosus are inflammatory diseases that affect the skin, joints and kidneys. White blood cells and antibodies accumulate and damage these tissues causing pain and organ failure. We have outlined a plan to identify the molecules that regulate the inflammation that cause these diseases in order to define the best targets for the next generation of drugs to treat these diseases.
|Gutierrez-Arcelus, Maria; Rich, Stephen S; Raychaudhuri, Soumya (2016) Autoimmune diseases - connecting risk alleles with molecular traits of the immune system. Nat Rev Genet 17:160-74|
|Frisell, Thomas; Hellgren, Karin; Alfredsson, Lars et al. (2016) Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden. Ann Rheum Dis 75:183-9|
|Gutierrez-Achury, Javier; Zorro, Maria Magdalena; RicaÃ±o-Ponce, Isis et al. (2016) Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis. Hum Mol Genet 25:180-90|
|Ellinghaus, David; Jostins, Luke; Spain, Sarah L et al. (2016) Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet 48:510-8|
|Han, Buhm; Pouget, Jennie G; Slowikowski, Kamil et al. (2016) A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases. Nat Genet 48:803-10|
|Ermann, Joerg; Rao, Deepak A; Teslovich, Nikola C et al. (2015) Immune cell profiling to guide therapeutic decisions in rheumatic diseases. Nat Rev Rheumatol 11:541-51|
|Diogo, DorothÃ©e; Bastarache, Lisa; Liao, Katherine P et al. (2015) TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS One 10:e0122271|
|Pers, Tune H; Karjalainen, Juha M; Chan, Yingleong et al. (2015) Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun 6:5890|
|Gutierrez-Achury, Javier; Zhernakova, Alexandra; Pulit, Sara L et al. (2015) Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat Genet 47:577-8|
|Trynka, Gosia; Westra, Harm-Jan; Slowikowski, Kamil et al. (2015) Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci. Am J Hum Genet 97:139-52|
Showing the most recent 10 out of 14 publications